Delivery Order SPE2DB24D2205-SPE2DB24FDZGK

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $43K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MULTAQ 400 MG TABLET 60S. The award, valued at $30,199.64, has a period of performance through September 18, 2024 and is a firm fixed price contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as a primary vehicle for...
This is a delivery order award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MULTAQ 400 MG TABLET 60S. The award ceiling value is $10,587.09 and the ultimate completion date is April 20, 2023. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $4,030.01 and is a firm fixed price delivery order with a period of performance through July 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not set aside for any specific business type. The contract is part of a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,504,610 MULTAQ 400 MG TABLET 60S. The contract has an ultimate completion date of August 20, 2024 and a ceiling value of $8,771.60. It is a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $2,248.11 and a performance period through March 26, 2024. The contract is a firm fixed-price, delivery order type, with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $12,239.04. The contract has a firm fixed price pricing type and an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $42,287.46, is for the delivery of MULTAQ 400 MG TABLET 60S, a prescription drug product. The contract has an ultimate completion date of June 21, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $83,745.88, is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The award has an ultimate completion date of April 10, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication MULTAQ 400 MG TABLET 60S. The contract has a ceiling value of $25,736.32 and is a firm fixed-price delivery order, with an ultimate completion date of May 6, 2025. The contract is not set aside and is open to competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MULTAQ 400 MG TABLET 60S. The contract is a firm fixed-price delivery order with a ceiling value of $66,147.94 and a period of performance through April 29, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDZGK
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price of $42,514.13 and a period of performance through August 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of medical commodities, including prescription drugs and medical supplies, to support military treatment programs and facilities worldwide. The current delivery order does not have a set-aside designation.

Generated 11/28/24, 9:06 AM